To amend title XVIII of the Social Security Act to require drug manufacturers to pay a Medicare part B rebate for certain drugs if the price of such drugs increases faster than inflation.
USA115th CongressHR-5150| House
| Updated: 3/9/2018
Sander M. Levin
Democratic Representative
Michigan
Cosponsors (4)
Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Protecting Medicare from Excessive Price Increases Act of 2018 This bill requires a drug manufacturer to pay a Medicare rebate on a single-source drug or biological in accordance with the extent to which the manufacturer's average sales price for the drug or biological increases faster than inflation.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Health
Business recordsCivil actions and liabilityCongressional oversightGovernment studies and investigationsHealth care costs and insuranceInflation and pricesManufacturingMedicarePrescription drugs
To amend title XVIII of the Social Security Act to require drug manufacturers to pay a Medicare part B rebate for certain drugs if the price of such drugs increases faster than inflation.
USA115th CongressHR-5150| House
| Updated: 3/9/2018
Protecting Medicare from Excessive Price Increases Act of 2018 This bill requires a drug manufacturer to pay a Medicare rebate on a single-source drug or biological in accordance with the extent to which the manufacturer's average sales price for the drug or biological increases faster than inflation.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Sander M. Levin
Democratic Representative
Michigan
Cosponsors (4)
Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Business recordsCivil actions and liabilityCongressional oversightGovernment studies and investigationsHealth care costs and insuranceInflation and pricesManufacturingMedicarePrescription drugs